Pharscin Pharmaceutical Co., Ltd. (Stock Abbreviation: Pharscin Pharmaceutical, Stock Code: 002907) is a national key high-tech enterprise and an A-share listed company on the Shenzhen Stock Exchange, integrating drug research and development, production, and sales. The company currently operates 22 production lines, including chemical raw material synthesis, botanical drug extraction, oral and injectable formulations, with a sales network covering 31 provinces and municipalities across China. Focusing on product R&D and academic promotion, and driven by its excellent corporate culture, Pharscin implements a brand strategy and has established a professional brand image in China's pharmaceutical industry.